Novus Therapeutics
Latest round
- Series E
Last raised
- May 2013
Total raised
- $57M
Investors
- 3
About Novus Therapeutics
Novus Therapeutics Inc.Novus Therapeutics Inc. was formed in May 2017 through the merger of Tokai Pharmaceuticals Inc., originally founded in 2004 and headquartered in Irvine, US.67 mn on April 30, 2019.Novus Therapeutics specializes in developing therapies focused on organ transplant outcomes, with a leading product, tegoprubart, an anti-CD40L antibody that regulates immune responses to mitigate organ rejection.Novus Therapeutics generates revenue from its clinical development programs around tegoprubart, engaging in partnerships with clinical trial sites and healthcare providers.Looking ahead, Novus Therapeutics plans to expand its product offerings and geographical footprint. The company is actively working on new therapies and exploring markets, specifically in North America and Europe.67 mn will be strategically utilized to support these initiatives, allowing Novus to progress its clinical trials and potentially enable future commercialization of its therapies.
Who invested in Novus Therapeutics
3 investors across 4 rounds
See all investors in Novus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Novus Therapeutics
Who invested in Novus Therapeutics?
Novus Therapeutics has 3 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Novus Therapeutics raised?
Novus Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Novus Therapeutics last raise money?
Novus Therapeutics's most recent round on record is a Series E, in May 2013.
What does Novus Therapeutics do?
Novus Therapeutics is a pharmaceuticals company.
Where is Novus Therapeutics headquartered?
Novus Therapeutics is headquartered in Irvine, US.
Which VCs invest in companies like Novus Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Novus Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Novus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.